Search results
Results from the WOW.Com Content Network
Likewise, the Thai government also stepped up its attempt to produce its homegrown vaccines amidst criticism, [9] with "ChulaCov19" and set to begin trials in May 2021. [10] Phase I testing of the NDV-HXP-S vaccine began at Mahidol University in March 2021. [11] [12] In July 2021, the National Vaccine Institute apologized for slow vaccine ...
A leaked health ministry document has prompted calls in Thailand for medical staff inoculated against COVID-19 to be given a booster of an mRNA vaccine, after it included a comment that such a ...
Media coverage of the COVID-19 pandemic includes reporting on the deaths of anti-vaccine advocates from COVID-19 as a phenomenon occurring during the COVID-19 pandemic. [1] [2] [3] The media also reported on various websites documenting such deaths, with some outlets questioning whether this practice was overly unsympathetic.
“Please understand that we can manage this,” Prayuth said as he received the second dose of his coronavirus vaccine. Thai villages isolated over variant find amid vaccine worry Skip to main ...
The Moderna COVID-19 vaccine, also known as Spikevax, [318] is an mRNA vaccine [319] produced by the American company Moderna, the U.S. National Institute of Allergy and Infectious Diseases, the U.S. Biomedical Advanced Research and Development Authority, and the Coalition for Epidemic Preparedness Innovations.
Boon Vanasin's claim that his group, a more than $800 million private medicine empire, was close to signing a deal for 20 million Pfizer-BioNTech coronavirus vaccines to import to Thailand was ...
A private Thai hospital was ordered on Sunday to stop advertising COVID-19 vaccinations for sale in advance on the grounds that no vaccine is yet approved in Thailand. Vibhavadi Hospital told ...
A preventive measure introduced in May; Thai Chana QR-code before entering a retail premise to track individual customers On 12 January, the World Health Organization (WHO) confirmed that a novel coronavirus was the cause of a respiratory illness in a cluster of people in Wuhan, Hubei, China, who had initially come to the attention of the WHO on 31 December 2019.